The 144th Annual Meeting of the Pharmaceutical Society of Japan (Yokohama)
Advanced Search

Session Details

Oral Presentation(C) Pharmaceutical Biology

Immune system and biological defense 1/Bioactive substances

Fri. Mar 29, 2024 3:30 PM - 4:30 PM JST
Fri. Mar 29, 2024 6:30 AM - 7:30 AM UTC
[Room 211] Conference Center 211+212 (2F)
Chair: Koji Hase, Kaori Denda-Nagai
3:30 PM - 3:42 PM JST(6:30 AM - 6:42 AM UTC)

[29-211-pm11S]CD20 promotes BCR/TLR9 dependent cell proliferation by increasing surface IgM expression.

○Yohei Kobayashi1, Yuri Shimizu1, Ryota Sato1, Ryutaro Fukui1, Takuma Shibata1, Kensuke Miyake1 (1. The Institute of Medical Science, The University of Tokyo)
3:42 PM - 3:54 PM JST(6:42 AM - 6:54 AM UTC)

[29-211-pm12]The role of Traf5 in the IgA production by mouse mucosal tissues

○Mari Hikosaka-Kuniishi1, Yuta Tsutsui1, Soichiro Kobayashi1, Mitsuki Azuma1, Kota Makara1, Sayaka Ogawara1, Chieri Iwata1, Tomomi Wakaizumi1, Masashi Morita1, Takanori So1 (1. Grad. Sch. Med. Pharm. Sci., Univ. of Toyama)
3:54 PM - 4:06 PM JST(6:54 AM - 7:06 AM UTC)

[29-211-pm13]Functional analysis of CGRP in ulcerative colitis using genetically engineered mice

○Tatsuya Shibao1, Koudai Mizokami1, Ryosuke Kurayama1, Atsuya Tashiro1, Kaori Kitae1, Yuko Ueda1, Kentaro Jingushi1, Hiroaki Hase1, Kazutake Tsujikawa1 (1. Grad. Sch. Pharm. Sci., Osaka Univ.)
4:06 PM - 4:18 PM JST(7:06 AM - 7:18 AM UTC)

[29-211-pm14]Search for small molecule biomarkers to predict therapeutic efficacy of immune checkpoint inhibitors

○Atsuya Tashiro1, Hiroaki Hase1, Kentaro Jinguushi1, Kazutake Tujikawa1 (1. Grad. Sch. Pharm. Sci., Osaka Univ.)
4:18 PM - 4:30 PM JST(7:18 AM - 7:30 AM UTC)

[29-211-pm15]Exploration of biologically active modified nucleosides and analysis of cancer associated signaling mechanisms

○Ryosuke Kurayama1, Takumi Yoshioka1, Shibao Tatsuya1, Atsuya Tashiro1, Kentaro Jingushi1, Kaori Kitae1, Yuko Ueda1, Hiroaki Hase1, Kazutake Tsujikawa1 (1. Grad. Sch. Pharm. Sci., Osaka Univ.)
Back to Category List